Board summary
Key figures
29,267
Registered population
57.0% aged 18–64
20.8%
Aged 65+
ICB 19.9% · England 17.9%
7.1%
Ethnic minority (non-White)
3.1% Asian · England 9.6%
45.7%
In IMD quintile 1
ICB 17.1% · England 21.0%
~12,792
Core20 residents (est.)
Resident basis; registered basis ~13,411 · see page 3
4,794
Hypertension register
+3.37% in 3 yrs · England +5.60%
348
SMI register
27.3% of Dover's
918
COPD register
Reviews +2.35% in 3 yrs
Forecast to 2030
5,736
Hypertension patients, 2030
+942 on today
71.1%
QRISK ≥20% on statins, 2030
+2.21pp over 3 yrs
5.7%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Asthma reviews leave unreviewed patients.
Annual review coverage is 67.7% (England 65.7%), leaving about 580 of 1,780 asthma register patients unreviewed; a recall audit can test register reach.
Heart failure and SMI checks fell.
Over 2023 to 2025, heart failure reviews fell 15.6% (England +8.7%) and SMI BMI checks fell 7.2 pp (England +5.1 pp), which may reflect.
Non-frail diabetes and BP control lead.
Non-frail diabetes HbA1c control reached 61.0% (England 57.4%) after rising +14.1% over 2023 to 2025, alongside 72.5% hypertension treatment to target (England 70.3%).
Population, age and ethnicity
Registered children (22.1%) and older adults (20.8%) both exceed England averages
Across 29,267 registered patients across three practices, Dover Town PCN balances distinct demographic demands. Children aged 0-17 represent 22.1% (6,482 patients), compared with 19.0% in Dover, 20.7% in NHS Kent and Medway ICB, and 19.6% in England. Patients aged 65+ account for 20.8% (6,095 patients), against 24.2% in Dover, 19.9% in NHS Kent and Medway ICB, and 17.9% in England. Primary list size is projected to grow 9.7% to 2030 (Dover 5.3%, ICB 6.0%, England 2.3%) under unverified modelling. Associated area Census residents are 92.9% White (7.1% ethnic minority), describing residential catchment rather than registered patients.
Age profile
65+: ICB 19.9%, England 17.9%
Ethnicity
Older people · falls rows are Dover local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Dover LA) | 1,557 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.6% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 61.0% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Dover LA) | 886 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Dover LA) | 25.9 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation affects 45.7% of patients and is uniform across all three practices
Across Dover Town PCN, 45.7% of registered patients live in the Core20 most deprived quintile (England 21.0%; Dover 22.9%; NHS Kent and Medway ICB 17.1%). High Street Surgery records 44.2% (4,321 estimated patients), while St James' Surgery records 45.5% (4,309 estimated patients). Buckland Medical Practice records 47.7% (4,781 estimated patients), with a practice range of 3.6 pp. Practice estimates sum to 13,411 patients, against 12,792 in the LSOA resident calculation.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
348
SMI register
1.19% recorded prevalence
366
Learning disability register
1.25% recorded prevalence
29
Care homes, 635 beds
In the PCN catchment
10.3%
Provide unpaid care
Dover, Census 2021
Learning disability prevalence is 1.2% (366 patients; Dover 0.8%, ICB 0.6%, England 0.6%) and severe mental illness is 1.2% (348 patients; Dover 1.1%, ICB 0.9%, England 1.0%). Catchment areas include 29 care homes (635 beds); Dover district records 10.3% unpaid carers and 8 rough sleepers. Inclusion-health registers exceed England rates, so ring-fencing capacity for annual health checks and care-home coordination could be prioritised.
Severe mental illness: physical health checks
SMI BMI recording fell 7.2 pp over 2023 to 2025 (England +5.1 pp) to 76.9% (England 82.1%), while blood pressure checks reached 82.5% (England 83.4%). Declining BMI recording risks missed cardiovascular prevention in severe mental illness.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
4,794
Hypertension register
+3.37%
Register growth, 3 yrs
Dover +6.06% · England +5.60%
−1.83pp
BP control, under 80
≤140/90 · −4.01pp aged 80+
+942
More patients by 2030
Forecast 5,736 (17.46%)
Hypertension case-finding and control
Recorded hypertension prevalence is 16.3% (4,794 patients), above England (15.2%) and the ICB (16.2%) but below Dover (18.3%), with three-year register growth of +3.4% trailing England (+5.6%). While 72.5% of patients are treated to target (England 70.3%), control fell 2.1 pp over 2023 to 2025 (England +2.5 pp). In patients aged 80+, blood pressure control fell 4.0 pp (England +1.8 pp) to 80.8% (England 81.2%), spanning from 72.9% at St James' Surgery and 79.7% at High Street Surgery to 86.2% at Buckland Medical Practice. Blood pressure control among patients aged 80+ has fallen below England, so auditing recall and titration protocols at practices trailing the benchmark is the priority.
Lipids and statins
Among patients with QRISK ≥ 20%, 66.5% receive lipid-lowering therapy (England 63.6%; Dover 62.6%), though three-year uptake grew +2.2 pp against England (+3.8 pp). Statin coverage in diabetes reaches 76.3% (England 73.2%). Although current uptake exceeds England, slower three-year growth highlights an opportunity to prioritise systematic primary prevention recall.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 46,793 | £2.90 | £1.90 | £1.86 | £135,700 |
| Cardiovascular (all), 2025 | 58,345 | £5.87 | £3.57 | £3.33 | £342,485 |
In 2026, the PCN prescribed 46,793 items for lipid-modifying drugs at £2.90 per item (Dover £2.27; ICB £1.90; England £1.86), spending £48,665 more than at England's unit cost, which may reflect formulary choices rather than inefficiency. Higher unit costs than England offer an opportunity to prioritise a collaborative pharmacy review of lipid prescribing.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+6.72%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+7.28%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 3.1% (918 patients; England 1.9%), following +23.1% three-year growth over 2023 to 2025 (England +2.6%). While 79.2% of COPD patients had an annual review (England 76.4%), asthma reviews reached 67.7% (England 65.7%), leaving an estimated 575 (about 580) of 1,780 asthma patients unreviewed. Furthermore, asthma prescribing for ages 5-19 is 1,636 items per 1,000 (England 1,488), and second-hand smoke recording reached 72.1% (England 78.8%). High paediatric prescribing alongside unreviewed patients highlights an opportunity to tighten structured review recall.
Cancer register and children's immunisation
Cancer prevalence is 4.9% (1,435 patients; England 3.8%). In childhood immunisations (Q1 2025/26), 6-in-1 at 12 months reached 90.5% (England 91.0%), but age-5 boosters trail: MMR dose 2 is 86.4% and the 4-in-1 booster is 84.1%, sitting below the 95.0% target by 8.6 pp and 10.9 pp. Across the age-5 cohort, MMR2 drops 5.6 pp below MMR1 (92.0%). Targeting pre-school booster drop-off is key to lifting coverage towards national protection thresholds.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
55.6%
Kent and Medway ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,630
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Kent and Medway ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 82.1% | 85.4% | 23% | 1,509 |
| Prostate | 54.4% | 53.2% | 37% | 1,435 |
| Lung | 29.4% | 33.8% | 21% | 1,109 |
| Bowel | 48.2% | 47.0% | 29% | 1,013 |
| Skin cancer | 87.5% | 87.8% | 23% | 562 |
In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB were diagnosed at stage 1 or 2 (4,661 of 8,384 staged cases; England 55.3%), against the 75.0% national ambition by 2028, with 63.6% known-stage completeness (8,384 of 13,189 cancers; England 67.0%). Reaching 75% requires about 1,630 extra early-stage cases a year across the ICB, where the early-stage share rose 2.2 pp from 53.4% in 2013. Lung early-stage diagnosis was 29.4% (England 33.8%). Dover Town PCN records 1,435 cancer register patients (4.9% prevalence); three-year register growth of +8.2% trailed Dover (+10.0%) and England (+9.0%). ICB staging describes wider system data rather than PCN performance.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In provisional July 2026 data, East Kent Hospitals University NHS Foundation Trust achieved 70.0% against the 85.0% 62-day cancer standard (ICB 75.9%, England 71.2%, Maidstone and Tunbridge Wells NHS Trust 87.4%, East Sussex Healthcare NHS Trust 67.0%). For the 28-day faster diagnosis standard, East Kent Hospitals achieved 71.3% against the 75.0% standard (ICB 76.8%, England 79.3%). In July 2026 diagnostics, 48.4% of patients waited 6+ weeks at the trust (England 23.1%), led by non-obstetric ultrasound at 63.0% (England 19.6%). These provider figures reflect acute system waiting times rather than PCN performance.
| Pathways within standard (%) | East Kent | East Sussex Healthcare | Maidstone and Tunbridge Wells | Kent and Medway ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.28 | 84.20 | 81.78 | 76.78 | 79.32 |
| 31-day treatment (96%) | 96.67 | 98.19 | 98.35 | 95.84 | 92.50 |
| 62-day referral to treatment (85%) | 70.01 | 67.04 | 87.43 | 75.93 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Kent | East Sussex Healthcare | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 47.58 | 6.48 | 0.92 | 21.40 |
| CT | 37.45 | 0.48 | 0.51 | 9.92 |
| Echocardiography | 14.17 | 21.94 | 2.57 | 28.48 |
| Colonoscopy | 9.58 | 0.74 | 19.80 | 30.83 |
| Gastroscopy | 22.16 | 0.31 | 24.03 | 29.02 |
| All 15 DM01 tests | 48.38 | 5.27 | 6.42 | 23.14 |
| Community services activity | Kent residents | Kent and Medway ICB |
|---|---|---|
| Care contacts | 210,170 | 254,055 |
| Referrals | 59,360 | 68,085 |
| Patients with a contact | 60,605 | 72,060 |
Community services (residents of Kent), Jun 2026 (provisional). In provisional June 2026 figures, Kent recorded 265,905 community care activities out of 297,595 across NHS Kent and Medway Integrated Care Board. Contacts with adults aged 65+ accounted for 65.8% of Dover borough residents' community contacts (138,250 of 210,170). Dover Town PCN records 20.8% of patients aged 65+ (England 17.9%). These community data describe wider local authority activity rather than PCN-level service delivery.
Practice variation and patient experience
Practices share similar deprivation yet diverge by 53.2 pp in vaccination achievement
In 2025/26, all three practices achieved 100.0% in QOF clinical points (England 97.1%). However, vaccination and immunisation achievement spans 53.2 pp, from 23.5% at St James' Surgery to 76.8% at Buckland Medical Practice (England 55.2%). This divergence could reflect operational differences in call-and-recall systems between member practices, to be evaluated through practice workflow review.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| High Street | 115 | 44.2 | 72.9% | 69.7% | 79.5% |
| St James' Surgery | 96 | 45.5 | 55.6% | 75.4% | 77.9% |
| Buckland Medical | 97 | 47.7 | 64.2% | 70.3% | 68.7% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Sixteen of 25 tracked indicators trail England over three years, led by reviews
Over 2023 to 2025, 16 of 25 tracked indicators trailed England's three-year change. The largest lags were in heart failure annual reviews, which fell 15.6% (England +8.7%; Dover -7.9%; ICB +8.5%), and severe mental illness BMI recording, down 7.2 pp (England +5.1 pp; Dover -1.7 pp). Registers for learning disability fell 3.3% (England +5.4%) and dementia fell 0.6% (England +6.0%). Conversely, non-frail diabetes HbA1c control rose 14.1% (England +4.4%), and asthma reviews rose 6.7% (England +4.4%). Slower monitoring and register declines may indicate recall pressure, which local audit should verify.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Heart failure reviews
BMI record (SMI)
Learning disability register
Alcohol record (psychosis)
BP control, 80+
Diabetes HbA1c control
Asthma reviews
Cervical screening
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Dover | Asset | PCN | Dover |
|---|---|---|---|---|---|
| Care homes (catchment) | 29 (635 beds) | n/a | Schools (catchment) | 49 | n/a |
| Children's centres | 5 | 7 | Places of worship | 29 | 106 |
| Libraries | 2 | 5 | Food banks (VCS) | 1 | 2 |
| Homelessness support (VCS) | 1 | 1 | Day centres (VCS) | 1 | 4 |
| Carers support groups (VCS) | 3 | 4 | Primary schools (LA maintained) | 9 | 19 |
| Primary academies | 8 | 21 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review recall
67.7% of the 1,780 asthma register patients had a recorded annual review (England 65.7%; Dover 62.0%; ICB 60.4%), leaving 575 (about 580) unreviewed. For discussion: run a single PCN asthma recall template with after-school and holiday review slots, checking inhaler prescribing and second-hand smoke status. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Heart failure register and review audit
Recorded prevalence is 0.8% (242 patients) vs 1.1% in Dover and England (crude gap +76 to +79 patients); annual reviews fell 15.6% over 2023 to 2025 (England +8.7%). For discussion: search hospital discharge letters for uncoded heart failure and establish a pharmacist-led annual functional capacity review recall list. Moderate effort to run.
Option 3
SMI and learning disability check recovery
SMI BMI recording is 76.9% (England 82.1%) on a 348-patient register, changing by -7.2 pp over 2023 to 2025 (England +5.1 pp), with St James' Surgery at 68.2% and High Street Surgery at 68.8%; the 366-patient learning disability register changed by -3.3% (England +5.4%). Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Age-weighted capacity planning (p2) | Aged 0-17 | Medium Term Planning Framework 2026 · Neighbourhood health framework | PCN |
| Networkwide Core20 proactive care model (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check recovery (p4) | Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
| Hypertension recall and titration audit (p5) | Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster outreach (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cancer referral safety netting audit (p7) | Cancer: QOF prevalence | Core20PLUS5, 75% stage 1–2 by 2028 | PCN |
| Practice access and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 Population | Core20PLUS5 respiratory | PCN |
| Option 2 · Heart failure register and review audit (p12) | Heart failure register · Heart Failure: QOF prevalence · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs) | — | PCN |
| Option 3 · SMI and learning disability check recovery (p12) | Severe mental illness register · SMI register with a BMI recorded in the last 12 months · Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs) | MHIS · From Harm to Hope · 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
